POMDOCTOR LIMITED
POM
Positions held
Your positionsPOM isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $7.32M | Enterprise value | $407.92M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -0.09 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 6.0% | Earnings growth | — | Gross margin | 12.0% | Operating margin | -125.9% |
| Profit margin | -90.2% | ROE | — | ROA | -3.5% | Debt / equity | — |
| Current ratio | 0.35 | Free cash flow | $4.10M | Analyst recommendation | none | Mean target | — |
| 52w high | $115.74 | 52w low | $0.50 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $400M | $343M | $305M | $245M |
| Op margin | -29.1% | -6.8% | -6.7% | -1.4% |
| Net income | -$213M | -$143M | -$145M | -$126M |
| Gross margin | 13.1% | 13.9% | 12.7% | 22.4% |
| Gross profit | $52.3M | $47.7M | $38.7M | $54.9M |
| Operating income | -$116M | -$23.4M | -$20.3M | -$3.3M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-30 · POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
2026-09-24 · POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model
2026-09-10 · POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
2026-08-27 · POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy
2026-08-10 · POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine
2026-08-03 · POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure
2026-07-13 · Pomdoctor Says It Has Regained Compliance with Nasdaq Minimum Bid Price Rule
2026-07-13 · POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
Price (daily)
Full chart · RSI · MACD · patterns